![](https://investorshub.advfn.com/uicon/40536.png?cb=1561902029)
Friday, May 10, 2019 7:59:25 PM
07 May 2019
Stem cells discovered against erectile dysfunction
The procedure is called CaverStem and involves the grafting of cells in the bone marrow directly into the male reproductive system.
Pretext of strong scientific, ethical, political and religious debate, that of stem cells is a recurrent argument among the most current scientific revelations. One of the most recent discoveries highlights the efficacy of some cells present in the bone marrow, namely hematopoietic, mesenchymal and endothelial progenitor cells, in counteracting erectile dysfunction. Thanks to an innovative medical protocol, in fact, it would be possible to reinvigorate blood vessels and smooth muscles of the male reproductive system with a natural and lasting treatment.
At the microphones of Adnkronos Salute, the urologist-andrologist Gabriele Antonini explains what CaverStem is about, the name of this procedure scientifically validated in the USA and now also available in Italy after the go-ahead by the Ministry of Health: "Hematopoietic progenitor cells are used , mesenchymal and endothelial cells present in the patient's bone marrow. The administration of stem cells directly into the penis can reverse the pathophysiological changes that lead to erectile dysfunction, in addition to treating the symptoms effectively. In about 15 minutes - continues Antonini - the urologist specialist proceeds under local anesthesia to extract a small quantity of autologous material from the iliac crest from the patient, and obtains a concentrated cellular product that is injected into the corpus cavernosum of the patient's penis same".
The only private European center authorized to administer this procedure is located in Rome. The dott. Antonini adds: "The CaverStem procedure makes it possible to carry out a safe, fast and free of collateral effects on an outpatient basis".
In Italy, an estimated 3 million men suffer from erectile dysfunction. The numbers could be even higher considering the reticence that the subject imposes, but with the research that takes giant steps this trend could know a change of direction.
Source: Adnkronos Health
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM